Medolway Life Sciences Private Limited

Medolway Life Sciences Private Limited - business services in Ambala Cantt, Haryana, India. FY 2026 financials & compliance.
CIN U74999HR2017PTC070743 Incorporated 12 September 2017 ROC Haryana HQ Ambala Cantt, Haryana, India
Active Private Limited Company business services
Revenue · FY 2025
₹5.47 Cr
▼ 12% YoY
Net profit · FY 2025
₹4.71 Lakh
Net margin 0.9%
EBITDA · FY 2025
₹7.39 Lakh
EBITDA margin 1.4%
Authorised capital
₹50,000
Registered with MCA
Paid-up capital
₹50,000
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Medolway Life Sciences Private Limited

Data last updated:

Medolway Life Sciences Private Limited is a private limited company based in Ambala Cantt, Haryana, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 12 September 2017 and has been in existence for over 9 years.

The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U74999HR2017PTC070743. Its GSTIN is 06AAZCS2131A1ZJ (Haryana).

The company has an authorised share capital of ₹50,000 and a paid-up capital of ₹50,000. It was formerly known as Crisol Life Sciences Private Limited and Solwaymed Biotech Private Limited. It is led by directors Pardeep Kumar and Ishant Sharma.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #25 – 26 Luxmipura Ambala Cantt, Haryana, India – 133001.

As per the financials filed for FY 2025, the company reported a revenue of ₹5.47 Cr, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹4.71 Lakh (net margin 0.9%) and EBITDA of ₹7.39 Lakh (EBITDA margin 1.4%). Revenue has grown at a compounded annual rate (CAGR) of 57% over three years and 66% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U74999HR2017PTC070743
Registration Number 070743
Incorporation Date 12 September 2017
ROC Haryana
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Name history

Medolway Life Sciences has undergone 2 name changes throughout its history. The company was previously known as Crisol Life Sciences Private Limited, and Solwaymed Biotech Private Limited. The current legal name is Medolway Life Sciences Private Limited.

Company NameStatus
Medolway Life Sciences Private LimitedCurrent
Crisol Life Sciences Private LimitedPrevious
Solwaymed Biotech Private LimitedPrevious

Contact details

Medolway Life Sciences Private Limited's registered office is in Ambala Cantt, Haryana. Its e-mail address is in the company report.

  • Email
  • Registered Address
    #25 – 26 Luxmipura Ambala Cantt, Haryana, India – 133001
  • Industry
    Business Services, Miscellaneous Business Activities, Other Services

To see the full contact details of Medolway Life Sciences Private Limited, buy the company report.

Comprehensive company report
Medolway Life Sciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Medolway Life Sciences is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Medolway Life Sciences Private Limited, buy the company report.

Financials of Medolway Life Sciences Private Limited

FY 2025 filings available

Medolway Life Sciences Private Limited reported revenue of ₹5.47 Cr (down 12% YoY) for FY 2025.

Revenue · FY 2025
₹5.47 Cr ▼ 12%
Net profit · FY 2025
₹4.71 Lakh margin 0.9%
EBITDA · FY 2025
₹7.39 Lakh margin 1.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 12%
3 years · compounded
▲ 57%
5 years · compounded
▲ 66%
EBITDA CAGR growth
1 year
▼ 16%
3 years · compounded
▲ 86%
5 years · compounded
▲ 79%

Revenue fell 12% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 66%. EBITDA fell 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹7.39 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹4.71 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin1.4%
Net Profit Margin0.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Medolway Life Sciences Private Limited, buy the company report.

Board of directors of Medolway Life Sciences Private Limited

Medolway Life Sciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Pardeep KumarDirector12 Sep 20179 Years 2 MonthsCurrent
Ishant SharmaDirector12 Sep 20179 Years 2 MonthsCurrent

Peer comparison

Medolway Life Sciences Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Contract Research, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Emdrix Pharmaceuticals Private Limited₹5.48 Cr (FY 2017)73.0%Bangalore, Karnataka, India
Pee Vee Products Private Limited₹5.48 Cr (FY 2025)14.0%Ahmedabad, Gujarat, India
Genome Therapeutics Private Limited₹5.47 Cr (FY 2025)14.0%Secunderabad, Telangana, India
Medolway Life Sciences Private Limitedthis company₹5.47 Cr (FY 2025)₹4.71 Lakh0.9%-12.0%Ambala Cantt, Haryana, India

To see the full peer comparison of Medolway Life Sciences Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Medolway Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Medolway Life Sciences has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
06AAZCS2131A1ZJHaryanaActive21 Sep 2017

To see the full GST registrations and return filing status of Medolway Life Sciences Private Limited, buy the company report.

Recent activity

Medolway Life Sciences Private Limited has 4 board changes on record since 2017: 3 appointments and 1 cessation. The latest: Arun Kumar ceased to be Director on 24 Mar 2022.

AGM
Medolway Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Medolway Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Haryana.
Ceased
Arun Kumar ceased to be Director.
Appointed
Arun Kumar was appointed as Director.
Appointed
Ishant Sharma was appointed as Director.
Appointed
Pardeep Kumar was appointed as Director.
Incorporation
12 Sep 2017
Medolway Life Sciences Private Limited was registered on 12 Sep 2017 with Roc Haryana & aged 9 years 2 months as per MCA records.

Frequently asked questions

Medolway Life Sciences is an active private limited company based in Ambala Cantt, Haryana, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 12 September 2017 (9+ years old) and is registered under CIN U74999HR2017PTC070743.

Medolway Life Sciences has 2 current directors:

The latest financial statements of Medolway Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.

The GSTIN of Medolway Life Sciences is 06AAZCS2131A1ZJ, registered in Haryana.

The CIN (Corporate Identification Number) of Medolway Life Sciences is U74999HR2017PTC070743. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Medolway Life Sciences was incorporated on 12 September 2017, making it 9+ years old. It is registered with the Registrar of Companies, Haryana.

The peers of Medolway Life Sciences by revenue are Emdrix Pharmaceuticals Private Limited, Pee Vee Products Private Limited, Genome Therapeutics Private Limited, all in the Pharma industry (Contract Research, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).

Arun Kumar ceased to be Director on 24 Mar 2022. Arun Kumar was appointed as Director on 12 Sep 2017. Ishant Sharma was appointed as Director on 12 Sep 2017. Medolway Life Sciences has 4 board changes on record in total.

The registered office of Medolway Life Sciences is at #25 – 26 Luxmipura Ambala Cantt, Haryana, India – 133001.

Medolway Life Sciences operates in the business services industry, in the miscellaneous business activities segment.

The compliance status of Medolway Life Sciences is compliant as of 05 July 2026. The company is actively filing with the Registrar of Companies.